Abstract
Adults with complex congenital heart disease (CHD) are at risk for cognitive dysfunction. However, associations between cognitive dysfunction and psychosocial outcomes are poorly defined. Between June and November 2022, we prospectively recruited 39 adults with complex CHD who completed a computerized cognitive assessment (Cogstate) and validated psychosocial scales measuring psychological distress, health-related quality of life (HRQOL), and resilience. Participants had a mean age of 36.4 ± 11.2 years. Over half (62%) were women, most (79%) had complex biventricular CHD, and 21% had Fontan physiology. Prevalence of cognitive dysfunction was greatest in the domains of attention (29%), working memory (25%), and psychomotor speed (21%). Adjusting for age and sex, Pearson partial correlations between Cogstate z-scores and self-reported cognitive problems were small. Participants who lived in the most disadvantaged areas and those with a below-average annual household income had lower global cognitive z-scores (p = 0.02 and p = 0.03, respectively). Two-thirds (64%) reported elevated symptoms of depression, anxiety, and/or stress. Small correlations were observed between psychological distress and cognitive performance. Greater resilience was associated with lower psychological distress (r ≥ −0.5, p < 0.001) and higher HRQOL (r = 0.33, p = 0.02). Our findings demonstrate that adults with complex CHD have a high risk of cognitive dysfunction, though may not recognize or report their cognitive challenges. Lower socioeconomic status may be an indicator for those at risk of poorer cognitive functioning. Psychological distress is common though may not be a strong correlate of performance-based cognitive functioning. Formal cognitive evaluation in this patient population is essential. Optimizing resilience may be a protective strategy to minimize psychological distress and bolster HRQOL.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The adult population living with complex congenital heart disease (CHD) is rapidly growing [1,2,3]. As long-term survival and clinical outcomes continue to improve, there is increasing focus on optimizing health-related quality of life (HRQOL) [4].
Neurodevelopmental delay and disability are common in infants with complex CHD [5,6,7,8] and can manifest as long-term cognitive deficits later in life [9,10,11,12,13,14,15,16]. Recent studies have demonstrated that broad cognitive dysfunction is observed in adults with complex CHD and is associated with CHD complexity [17,18,19,20]. Adults with CHD may also experience elevated psychological distress and have poorer social and educational outcomes compared with healthy aging adults [4], including challenges at school, the workplace, and in relationships [21]. Socioeconomic status may be a key determinant of neurodevelopmental and psychological outcomes [22,23,24,25] and combined these factors can have a significant impact on overall HRQOL [26,27,28]. Unlike in children with CHD, the impact of cognitive dysfunction on broader health and psychosocial functioning in adults with complex CHD is poorly characterized. Understanding associations between cognitive functioning and psychosocial factors is essential for guiding targeted intervention strategies to optimize long-term cognitive functioning and overall well-being. The aim of the current study was to characterize associations between performance-based measures of cognitive functioning and self-report measures of psychosocial and socioeconomic factors in adults with complex CHD. We hypothesized that poorer cognitive performance would be associated with lower socioeconomic status and HRQOL, and higher levels of psychological distress. Our secondary hypotheses were that greater resilience would be associated with lower levels of psychological distress and greater HRQOL.
Methods
Participants
Ethics approval was obtained from the Sydney Local Health District Ethics Review Committee (RPAH Zone; 2021/ETH01181) and all participants provided written informed consent. Individuals with complex CHD aged 18 years or older were prospectively recruited as part of the Congenital Heart Disease Fitness Intervention Trial (CH-FIT) [29]. Classification of complex CHD included patients with moderate to severe CHD as defined by European Society of Cardiology disease classification guidelines [30]. Participation took place at the Royal Prince Alfred Hospital in Sydney, Australia between June and November 2022. Individuals with severe verbal comprehension difficulties impacting the capacity to understand task instructions were not included. Broader exclusion criteria for CH-FIT are described by Tran et al. [29]
Cognitive Assessment
Participants completed a computerized cognitive assessment called Cogstate (Melbourne, Australia). The Cogstate battery consisted of a series of tests measuring psychomotor speed, processing speed, attention, visual learning and memory, verbal learning and memory, working memory, executive function, and social-emotional cognition. The full battery took approximately 45 min to complete. Assessments were administered in-person by a trained research assistant in a quiet assessment room with minimal distractions. Raw scores were transformed to z-scores using age-matched normative data. Where relevant, z-scores were reversed so lower scores reflected poorer performance; z-scores were used in all analyses. A global cognitive composite score was generated by summing the primary outcome z-score from each test and dividing by the total number of tests. In accordance with Cogstate guidelines, z-scores between >1 and 2 SD below normative means were indicative of mild cognitive dysfunction and aligned with performance below the 16th percentile of functioning in a normative sample. Scores ≥2 SD below normative means were classified as severe cognitive dysfunction representing performance at or below the 2nd percentile of functioning compared to population norms [31]. In other clinical cohorts, a z-score of >1 SD below normative mean on Cogstate demonstrates optimal sensitivity for detecting mild cognitive decline [31].
Participants completed the Conners’ Adult ADHD Rating Scales Self-Report Short Version (CAARS S:S) [32] to assess behaviors and symptoms indicative of attention-deficit hyperactivity disorder (ADHD). The CAARS S:S generates an ADHD Index and four factor-derived subscales; (1) Inattention/Memory Problems, (2) Hyperactivity/Restlessness, (3) Impulsivity/Emotional Lability, and (4) Problems with Self-Concept. Raw scores were converted to t-scores using age- and sex-normative data. A cut-off t-score of ≥65 (i.e., ≥1.5 SD from the mean) indicated challenges consistent with ADHD. The Autism Quotient-10 (AQ10) [33] was used to assess symptoms indicative of possible autism spectrum disorder. A cut-off score of >6 suggests a person should be considered for clinical assessment.
Evaluation of Sociodemographic Factors
Sociodemographic factors were self-reported and included country of birth, primary language, marital status, residential address, living circumstance, highest achieved level of education, employment status, and gross annual household income. Geographical remoteness was determined using the Australian Statistical Geography Standard—Remoteness Classification [34]. Socioeconomic disadvantage was assessed using the Australian Index of Relative Socio-Economic Advantage and Disadvantage [35] which categorizes areas based on census information about the economic and social conditions of people and households within the area. Annual household income was categorized according to those with an annual household income below the Australian mean (i.e., ≤$120,000 Australian dollars) versus those with above (Australian Bureau of Statistics) [36].
Evaluation of Psychosocial Factors
A lifetime psychological disorder referred to a person being diagnosed with a psychological condition at some time in their life [37].
Depression, Anxiety and Stress Scales (DASS-21, 21 items) assessed symptoms of psychological distress. Items range from 0 (“Never”) to 3 (“Almost always”). Higher scores indicate greater distress and were classified as normal, mild, moderate, severe, or extremely severe, based on the scale manual [38].
Cardiac Anxiety Questionnaire (CAQ) [39] includes 18 items that assessed cardiac-related anxiety. Items are scored on a 5-point Likert scale (0–4), with higher scores indicating greater anxiety.
Impact of Events Scale—Revised (IES-R) evaluated traumatic stress symptoms along three dimensions; intrusion, avoidance, and hyperarousal on a 5-point Likert scale (0–4), with all items anchored to congenital cardiac diagnosis. Higher scores indicate greater traumatic stress.
Pediatric Quality of Life Inventory 4.0 Generic Core Scale (PedsQL) was administered to evaluate HRQOL [40, 41]. The scale includes 23-items that encompass physical, emotional, social, and school/work functioning. Three summary scores are calculated (1) Physical Health Summary Score (2) Psychosocial Health Summary Score that comprises emotional functioning, social functioning, and school functioning and (3) Total Scale Score (HRQOL score) that encompasses all scores. Participants also completed the PedsQL 3.0 Cardiac Module. The cognitive problems score was included in the current analysis to measure self-reported cognitive functioning. Items on both the PedsQL Generic Core 4.0 and Cardiac 3.0 scales are rated using a 5-point Likert scale, scores are reversed and transformed to scaled scores that range from 0 to 100, with higher scores representing greater HRQOL.
Resilience was measured using the 10-Item Conner-Davidson Resilience Scale (CD-RISC-10). Items are scored on a 5-point Likert scale (0–4), with higher scores indicating greater resilience [42].
The Coronavirus Anxiety Scale [43] was included to account for anxiety that was experienced at the time of the study in response to the COVID-19 pandemic. Items are scored on a 5-point Likert scale (0–4), a total score ≥9 indicates probable dysfunctional coronavirus-related anxiety.
All questionnaires were completed within 1 month prior to completing the Cogstate assessment (mean 3.4 ± 7.3 days).
Statistical Analysis
Data were analyzed using IBM SPSS Version 28 (IBM Corp). All data were evaluated for normality of distribution prior to analysis; normality was observed for all variables. Continuous variables were summarized using mean and SD and categorical variables were summarized using frequencies and percentages. Sociodemographic factors from the study cohort are qualitatively described in comparison to the latest Australian census population data (www.abs.gov.au/statistics).
Pearson partial correlation coefficient adjusting for age and sex as covariates was used to analyze the relationship between Cogstate z-scores and continuous variables. Correlation coefficients were interpreted according to published guidelines as small (r value between 0.1 and 0.29), moderate (0.3–0.49), and strong (≥0.5) [44, 45]. To analyze associations between Cogstate z-scores and categorical variables, two sample t tests and one-way ANOVA were used to compare means across levels of categorical data, mean difference and 95% confidence intervals (CI) are reported. Adjustment for multiple comparisons was not performed as this was an exploratory analysis. A p value of <0.05 was used to determine statistical significance.
Results
Participant Characteristics
Thirty-nine participants completed the Cogstate and psychosocial assessment. Sociodemographic and clinical characteristics are reported in Tables 1 and 2, respectively. No participants reported a previous diagnosis of stroke or brain injury. One participant had DiGeorge syndrome but scored within an average range on all measures of cognitive functioning. Thirty-five (90%) participants had completed ≥12 years of education which is identical to the rate reported in the general Australian population. Forty-two percent (n = 16) of the cohort had completed an undergraduate university degree or higher in comparison to 32% of the Australian population. Eleven (28%) participants reported that they had difficulties with learning at school; however, only 5 people (13%) had completed any formal evaluation to better understand these challenges. The rate of unemployment in our sample was higher than the national average (8% versus 3.5%, respectively) and four (10%) participants were receiving government-funded financial assistance relating to unemployment or disability.
Cognitive Functioning
Proportion and severity of cognitive dysfunction across the domains assessed are displayed in Fig. 1. Mean global cognitive composite z-score was −0.02 ± 0.46 and mean z-scores for psychomotor speed, attention, and working memory were below the normative mean, though within an average range (Table 3). While no participants had a global composite score within the ‘impaired’ range (i.e., z-score < −1), 8 (21%) participants exhibited dysfunction in ≥3 cognitive domains, indicating broad cognitive challenges. Women had a lower mean psychomotor speed z-score compared with men (−0.67 versus −0.12, respectively, p = 0.01), no other differences in cognitive functioning were observed based on sex. Participants with a Fontan circulation had lower mean processing speed z-scores compared with participants with complex biventricular CHD (−0.32 versus 0.16, respectively, p = 0.03). When grouped by complexity, participants with severe CHD had lower verbal memory z-scores compared with participants with moderate CHD (0.01 versus 0.55, respectively, p = 0.04).
No participants had a diagnosis of autism spectrum disorder, and 2 (5%) participants had an existing diagnosis of an attention disorder. The proportion of participants that scored above the cut-off threshold on the CAARS S:S and AQ10 are reported in Table 3. Only one of the participants who scored above the clinical threshold on the ADHD Index had previously been diagnosed with an attention disorder.
Psychological Outcomes
Sixteen (41%) participants reported a lifetime diagnosis of a psychological condition (50% of females and 27% of males), including depression (33%; 42% of females and 20% of males), anxiety (23%; 29% of females and 13% of males), and post-traumatic stress disorder (8%; 13% of females and no males). Of these, 8 (21%) had a comorbid psychological diagnosis (Table 2). Seventeen participants (94%) who had been diagnosed with a psychological condition had received support or therapy from a psychiatrist or psychologist and 7 (44%) had previously or were currently taking prescribed psychotropic medication associated with a psychological condition. Twenty-five (64%) participants reported currently elevated levels of psychological distress, including depression (26%), anxiety (48%), and stress (33%) (Table 4). Participants with a Fontan circulation reported significantly higher levels of anxiety compared to the biventricular complex CHD group (mean difference = −2.67, [95% CI = −5.02, −0.33], p = 0.01). When grouped by severity, no significant differences in levels of depression, anxiety, and stress were reported between those with moderate versus severe CHD. Mean resilience score indicated that the group scored in the lowest quartile compared to population norms (mean = 27.67 ± 6.47) [42]. No participants indicated elevated anxiety related to COVID-19.
Associations Between Cognitive Functioning, Sociodemographic, and Psychosocial Factors
Cognition and Sociodemographic Factors
A significant difference in mean global cognitive composite z-scores was identified based on the Index of Socioeconomic Advantage and Disadvantage (F = 3.23(4, 34), p = 0.02); Tukey post hoc tests showed people living in the most disadvantaged areas had a lower global cognitive composite z-score compared with people living in the most advantaged areas (mean difference = −0.69, p = 0.02). Participants with an annual household income below the Australian average had a lower mean global cognitive composite z-score (mean difference = −0.42, [95% CI = −0.8 to −0.4], p = 0.03) and mean executive functioning z-score (mean difference = −0.64, [95% CI = −1.28 to −0.01], p < 0.05) compared with those with an annual household income above the Australian average. Lower visual learning z-scores were observed in participants who were single compared to those in a relationship (mean difference = −0.76 [95% CI = −1.3 to −0.22], p = 0.01) and participants who were living with parents or relatives compared to those living independently or with a partner (mean difference = −0.88, [95% CI = −1.58 to −0.18], p = 0.01).
Participants who had completed a university degree had higher mean z-scores in the global cognitive composite (mean difference = 0.29, [95% CI = −0.58 to 0.01], p = 0.03), attention (mean difference = 0.58, [95% CI = 1.15 to 0.004], p = 0.02), and visual learning (mean difference = 0.66, [95% CI = 1.21 to 0.09], p = 0.01) compared with those who did not have a university degree. Differences in Cogstate z-scores based on employment status were not evaluated due to small sample sizes.
Cognition, Psychological Factors, and HRQOL
Correlations between Cogstate z-scores and depression, anxiety, stress, and cardiac-related anxiety scores were small (Table 5).
Moderate correlations were observed between patient-reported physical health and global cognitive composite z-score (r = 0.34, p = 0.04) and visual learning (r = 0.37, p = 0.03). Correlations between patient-reported cognitive problems and Cogstate z-scores were small (Table 5). Moderate-to-strong negative correlations were identified between psychological distress and psychosocial health summary scores and HRQOL (r ≤ 0.35, p ≤ 0.01) (Table 6).
Correlations between Cogstate z-scores and resilience were all small. However, moderate-to-strong negative correlations were identified between resilience and depression (r = −0.52, p < 0.001), anxiety (r = −0.65, p < 0.001), and stress scores (r = −0.35, p = 0.02). Moderate positive correlations were identified between resilience and HRQOL (r = 0.33, p < 0.02) and psychosocial health summary scores (r = 0.3, p = 0.04) (Table 6).
Discussion
Long-term survival of individuals with complex CHD has dramatically improved over recent decades due to advances in surgical strategies and clinical care [2, 3]. Good long-term clinical outcomes are predominantly defined in terms of cardiac function and physiological health status; however, there is growing recognition of the cognitive [17,18,19,20] and psychological sequelae [4] experienced by this cohort which can impact physical and psychosocial health [4, 21, 46]. Associations between cognitive functioning and psychosocial factors in adults with complex CHD are poorly characterized. The current findings add to a growing body of literature that demonstrates a high prevalence of cognitive dysfunction in adults with complex CHD [18,19,20]. Cognitive functioning was correlated with socioeconomic factors; however, small correlations were observed between performance-based cognitive scores and self-reported psychosocial functioning. Greater resilience was strongly associated with lower psychological distress and higher HRQOL.
Common areas of cognitive dysfunction identified in the current sample included attention, working memory, psychomotor speed, and visual memory, that have similarly been reported in others adult CHD cohorts [18,19,20, 47, 48]. Elevated symptoms associated with ADHD were also frequent. Consistent with our previously reported findings, processing speed was slower in adults with a Fontan circulation compared with adults with biventricular complex CHD [20]. Adults with severe CHD had poorer verbal memory compared to those with moderate CHD. Importantly, our results suggest that adults with complex CHD may not recognize or report their cognitive challenges, highlighting the need for routine cognitive evaluation in this cohort to ensure adequate support is in place to optimize functional outcomes. Establishing clear referral pathways to neuropsychology services are essential. The use of screening tools may help to identify new or worsening cognitive and psychological dysfunction and assist in the referral process. Research investigating the sensitivity of screening measures such as self- and informant-questionnaires or computerized cognitive batteries in complex CHD cohorts are warranted to guide the application of these resources within the ACHD clinic. Global cognitive functioning was lower for individuals who were more socioeconomically disadvantaged. Similar findings have been demonstrated in younger complex CHD cohorts [22,23,24] and may reflect barriers to accessing neurodevelopmental screening, follow-up, and/or interventional services [49], differences in early-life environmental experiences and cognitive stimulation [50, 51], as well as cognitive heritability [52]. Hypothesized gene–environment interaction models suggest there is an interaction between cognitive-associated genetic predisposition and socioeconomic status that drives long-term cognitive outcomes [53,54,55]; however, these findings are variable and may particularly apply to families with higher socioeconomic status [56, 57]. Reduced cognitive functioning may limit employment opportunities and contribute to socioeconomic disparity in adulthood.
Currently, access to neuropsychological services for people with complex CHD in Australia is limited and costly [58], which compounds the high financial burden associated with having a complex cardiac condition [59]. Minimizing socioeconomic barriers that limit access to neuropsychological services for people with complex CHD is becoming a recognized health priority [60]. Higher socioeconomic status is considered a protective factor against cognitive decline in healthy aging adults [61, 62]. Early cognitive decline and dementia is predicted to be an impending issue for the growing adult CHD population [63, 64], and socioeconomic status may serve as an indicator for adults with complex CHD who may require closer monitoring.
Cognitive challenges in children with complex CHD are associated with lower academic performance and achievement [11, 14, 65, 66]. In the current cohort, lower global cognitive functioning and poorer attention and visual learning were identified in those who had lower educational attainment compared with those who had attained a university level degree. While we cannot determine whether lower cognitive functioning was a barrier to accessing higher level education in this sample, identifying cognitive challenges in people with complex CHD is vital to promote engagement with remedial academic services that may subsequently bolster higher level academic achievement and employment opportunities [67].
The prevalence of a diagnosed psychological condition in our adult complex CHD sample was similar to the general Australian population (41% versus 44%, respectively); however, a considerably greater number of participants had received a diagnosis of depression (33% versus 11% of Australian population [37]) which is consistent with reports from other adult CHD cohorts [68,69,70]. Elevated levels of psychological distress (i.e., depression, anxiety, and stress) impacted two-thirds of our cohort and correlated strongly with overall psychosocial functioning, suggesting that mental health challenges are negatively impacting social and occupational functioning. Greater resilience correlated with lower psychological distress and greater HRQOL, which has been reported in both child and adult CHD populations [71]. Therapies focused on optimizing psychological resilience in people with CHD are anticipated to have broad benefits for overall health and well-being [4, 71, 72]. Combined cognitive and psychological intervention may optimize functional outcomes [73].
Of the participants who had a lifetime diagnosis of a psychological condition, 44% had taken prescribed psychotropic medications at some point. Promisingly, 92% had received therapy from a psychiatrist or psychologist. While this indicates good access to services for those who have sought medical treatment, it also highlights the high service utilization and needs associated with psychological sequelae in adults with complex CHD. Given the relative socioeconomic advantage and geographical location of our current cohort of urban-dwelling adult complex CHD patients, the generalizability of this finding to the broader adult CHD population is likely limited. Socioeconomic disadvantage is recognized as a predominant barrier to accessing mental health services [74]. The current findings may not reflect people who live in more remote/rural areas who have been found to have poorer access to mental health services in Australia [74, 75]. Consistent with this, low utilization of other recommended clinical services, including cardiopulmonary exercise testing, has been reported in people with complex CHD in rural regions of Australia [76]. Access to clinical neuropsychology services for all adults with CHD is fundamental [4].
Somewhat surprisingly, correlations between severity of psychological distress and cognitive functioning in our cohort were negligible. In other clinical and ‘healthy’ cohorts, strong associations have been identified between severity of psychological distress and cognitive functioning [77,78,79]. Despite the high prevalence of psychological distress experienced in our current and other adult CHD cohorts [68, 70], our findings may suggest that reduced cognitive functioning observed in adults with complex CHD is predominantly due to organic neurocognitive dysfunction, i.e., the structural changes observed in the brain of people with complex CHD [80, 81]. Significant associations between reduced brain volumes and cognitive functioning have been demonstrated in both children and adults with complex CHD [20, 82,83,84,85]. Associations between altered white matter microstructure and poorer cognitive functioning have also been identified, however are not fully established [86,87,88,89,90,91]. Future research is required to determine the mediating impact of psychological distress on these associations. It is likely that cognitive outcomes are determined by a complex and dynamic interplay of neurobiological, physiological, and psychosocial factors that occur across the lifespan of people with complex CHD [92].
Correlations between cognitive functioning and patient-reported psychosocial health and HRQOL were also weak, which may be reflective of the discordance between self-reported cognitive functioning and performance-based cognitive outcomes demonstrated in our current cohort. In contrast, significant moderate correlations were observed between patient-reported physical health and cognitive functioning. The physical functioning scale on the PedsQL has a key focus on abilities relating to exercise and physical fitness (e.g., ‘it is difficult for me to play sport or do exercise’). A growing literature highlights associations between physical fitness, exercise, and cognitive functioning in healthy and clinical populations [93,94,95,96,97,98]. In the first study of its kind, Cooney et al. (2021) demonstrated significant associations between exercise capacity and sustained attention and adaptive functioning in people with a Fontan circulation [99]. Poorer exercise capacity in people with complex CHD may reflect worse physiology [100, 101] which possibly underpins associations with cognitive outcomes. Further research including detailed phenotyping is required to better understand associations between physical health and fitness and cognitive functioning in adults with complex CHD. However, evidence suggests that exercise may be a cost-effective and accessible intervention to optimize both physical and cognitive functioning in people living with complex CHD [102,103,104].
Limitations
The current sample is relatively small and no demographically matched control participants were included. Overall, the sociodemographic profile of our cohort was generally higher than the general Australian population; however, this likely reflects the study location and recruitment strategies and may not be reflective of the sociodemographic status of adults living with complex CHD more generally. Despite this, a high proportion of our cohort demonstrated cognitive dysfunction and psychological distress, which may in fact underestimate the burden of these challenges across the adult complex CHD population more broadly.
Conclusion
Adults with complex CHD are at risk for cognitive dysfunction and may not recognize or report their cognitive challenges. Poorer performance-based cognitive functioning was associated with lower socioeconomic resources. Elevated levels of psychological distress were common but associations with cognitive performance were small. Formal cognitive evaluation in this cohort is essential to ensure appropriate support is in place to optimize day-to-day functioning. Resilience was inversely associated with psychological distress and may be a modifiable, protective factor for reducing psychological symptoms and optimizing HRQOL.
References
Plappert L, Edwards S, Senatore A, De Martini A (2021) The epidemiology of persons living with Fontan in 2020 and projections for 2030: development of an epidemiology model providing multinational estimates. Adv Ther 39(2):1004–1015
d’Udekem Y, Iyengar AJ, Galati JC, Forsdick V, Weintraub RG, Wheaton GR et al (2014) Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation 130(11 Suppl 1):S32–S38
Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM et al (2019) 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 73(12):1494–1563
Kovacs AH, Brouillette J, Ibeziako P, Jackson JL, Kasparian NA, Kim YY et al (2022) Psychological outcomes and interventions for individuals with congenital heart disease: a scientific statement from the American Heart Association 15(8):e000110
Butler SC, Sadhwani A, Stopp C, Singer J, Wypij D, Dunbar-Masterson C et al (2019) Neurodevelopmental assessment of infants with congenital heart disease in the early postoperative period. Congenit Heart Dis 14(2):236–245
Walker K, Badawi N, Halliday R, Stewart J, Sholler GF, Winlaw DS et al (2012) Early developmental outcomes following major noncardiac and cardiac surgery in term infants: a population-based study. J Pediatr 161(4):748–52.e1
Latal B (2016) Neurodevelopmental outcomes of the child with congenital heart disease. Clin Perinatol 43(1):173–185
Clancy T, Jordan B, de Weerth C, Muscara F (2020) Early emotional, behavioural and social development of infants and young children with congenital heart disease: a systematic review. J Clin Psychol Med Settings 27(4):686–703
Bellinger DC, Wypij D, duPlessis AJ, Rappaport LA, Jonas RA, Wernovsky G et al (2003) Neurodevelopmental status at eight years in children with dextro-transposition of the great arteries: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg 126(5):1385–1396
Cassidy AR, White MT, DeMaso DR, Newburger JW, Bellinger DC (2015) Executive function in children and adolescents with critical cyanotic congenital heart disease. J Int Neuropsychol Soc 21(1):34–49
Bellinger DC, Wypij D, Rivkin MJ, DeMaso DR, Robertson RL, Dunbar-Masterson C et al (2011) Adolescents with d-transposition of the great arteries corrected with the arterial switch procedure 124(12):1361–1369
Hövels-Gürich HH, Seghaye MC, Schnitker R, Wiesner M, Huber W, Minkenberg R et al (2002) Long-term neurodevelopmental outcomes in school-aged children after neonatal arterial switch operation. J Thorac Cardiovasc Surg 124(3):448–458
Sanz JH, Berl MM, Armour AC, Wang J, Cheng YI, Donofrio MT (2017) Prevalence and pattern of executive dysfunction in school age children with congenital heart disease. Congenit Heart Dis 12(2):202–209
Shillingford AJ, Glanzman MM, Ittenbach RF, Clancy RR, Gaynor JW, Wernovsky G (2008) Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics 121(4):e759–e767
Schaefer C, von Rhein M, Knirsch W, Huber R, Natalucci G, Caflisch J et al (2013) Neurodevelopmental outcome, psychological adjustment, and quality of life in adolescents with congenital heart disease. Dev Med Child Neurol 55(12):1143–1149
Wotherspoon JM, Eagleson KJ, Gilmore L, Auld B, Hirst A, Johnson S et al (2020) Neurodevelopmental and health-related quality-of-life outcomes in adolescence after surgery for congenital heart disease in infancy 62(2):214–220
Rodriguez CP, Clay E, Jakkam R, Gauvreau K, Gurvitz M (2021) Cognitive impairment in adult CHD survivors: a pilot study. Int J Cardiol Congenit Heart Dis 6:100290
Ilardi D, Ono KE, McCartney R, Book W, Stringer AY (2017) Neurocognitive functioning in adults with congenital heart disease. Congenit Heart Dis 12(2):166–173
Tyagi M, Fteropoulli T, Hurt CS, Hirani SP, Rixon L, Davies A et al (2017) Cognitive dysfunction in adult CHD with different structural complexity. Cardiol Young 27(5):851–859
Verrall CE, Yang JYM, Chen J, Schembri A, d’Udekem Y, Zannino D et al (2021) Neurocognitive dysfunction and smaller brain volumes in adolescents and adults with a Fontan circulation. Circulation 143(9):878–891
Kovacs AH, Bellinger DC (2021) Neurocognitive and psychosocial outcomes in adult congenital heart disease: a lifespan approach. Heart (British Cardiac Society) 107(2):159–167
Bucholz EM, Sleeper LA, Goldberg CS, Pasquali SK, Anderson BR, Gaynor JW et al (2020) Socioeconomic status and long-term outcomes in single ventricle heart disease. Pediatrics. 146(4):e20201240
Ramanan S, Sundaram S, Gopalakrishnan A, Anija DV, Sandhya P, Jose DS et al (2021) Intermediate-term neurodevelopmental outcomes and quality of life after arterial switch operation beyond early neonatal period. Eur J Cardiothorac Surg 60(6):1428–1436
Majeed A, Rofeberg V, Bellinger DC, Wypij D, Newburger JW (2022) Machine learning to predict executive function in adolescents with repaired d-transposition of the great arteries, tetralogy of Fallot, and Fontan palliation. J Pediatr 246:145–153
Neukomm A, Ehrler M, Feldmann M, Chaouch A, Knirsch W, Hagmann C et al (2022) Perioperative course and socioeconomic status predict long-term neurodevelopment better than perioperative conventional neuroimaging in children with congenital heart disease. J Pediatr 251:140–8.e3
Marino BS, Beebe D, Cassedy A, Riedel M, Burger M, Medek S et al (2011) Executive functioning, gross motor ability and mood are key drivers of poorer quality of life in child and adolescent survivors with complex congenital heart disease. J Am Coll Cardiol. 57(14 Suppl):E421
Holland JE, Cassidy AR, Stopp C, White MT, Bellinger DC, Rivkin MJ et al (2017) Psychiatric disorders and function in adolescents with tetralogy of Fallot. J Pediatr 187:165–173
Luyckx K, Goossens E, Rassart J, Apers S, Vanhalst J, Moons P (2014) Parental support, internalizing symptoms, perceived health status, and quality of life in adolescents with congenital heart disease: influences and reciprocal effects. J Behav Med 37(1):145–155
Tran D, Gibson H, Maiorana A, Verrall C, Baker D, Clode M et al (2022) Exercise intolerance, benefits, and prescription for people living with a Fontan circulation: the Fontan Fitness Intervention Trial (F-FIT)—rationale and design. Front Pediatr 9:799125
Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP et al (2021) 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 42(6):563–645
Maruff P, Lim YY, Darby D, Ellis KA, Pietrzak RH, Snyder PJ et al (2013) Clinical utility of the Cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer’s disease. BMC Psychol 1(1):30
Conners CK, Erhardt D, Sparrow E (1999) Conners’ adult ADHD rating scales (CAARS). Multi-Health Systems, Inc, Toronto
Allison C, Auyeung B, Baron-Cohen S (2012) Toward brief “Red Flags” for autism screening: the Short Autism Spectrum Quotient and the Short Quantitative Checklist for Autism in toddlers in 1,000 cases and 3,000 controls [corrected]. J Am Acad Child Adolesc Psychiatry 51(2):202–12.e7
Australian Bureau of Statistics (2016) Australian Statistical Geography Standard: Australian Bureau of Statistics. 2. https://www.abs.gov.au/statistics/statistical-geography/australian-statistical-geography-standard-asgs
Australian Bureau of Statistics (2018) Socio-economic indexes for areas. SEIFA. www.abs.gov.au/websitedbs/censushome.nsf/home/seifa
Australian Bureau of Statistics (2020) Household income and wealth 2020. https://www.abs.gov.au/statistics/economy/finance/household-income-and-wealth-australia/2019-20
Australian Bureau of Statistics. National Study of Mental Health and Wellbeing Canberra 2020–2021. https://www.abs.gov.au/statistics/health/mental-health/national-study-mental-health-and-wellbeing/latest-release
Lovibond SH, Lovibond PF (1995) Manual for the depression anxiety stress scales, 2nd edn. Psychology Foundation, Sydney
Eifert GH, Thompson RN, Zvolensky MJ, Edwards K, Frazer NL, Haddad JW et al (2000) The cardiac anxiety questionnaire: development and preliminary validity 38(10):1039–1053
Varni JW, Seid M, Kurtin PS (2001) PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 39(8):800–12
Uzark K, Jones K, Burwinkle TM, Varni JW (2003) The Pediatric Quality of Life Inventory™ in children with heart disease. Prog Pediatr Cardiol 18(2):141–149
Campbell-Sills L, Stein MB (2007) Psychometric analysis and refinement of the Connor–Davidson Resilience Scale (CD-RISC): validation of a 10-item measure of resilience. J Traumatic Stress. 20(6):1019–28
Lee SA (2020) Coronavirus Anxiety Scale: a brief mental health screener for COVID-19 related anxiety. Death Stud 44(7):393–401
Gravetter FJ, Wallnau LB (2007) Statistics for the behavioral sciences, 7th edn. Thomson Wadsworth, Belmont, CA, pp xxi, 759–xxi
Cohen J (2013) Statistical power analysis for the behavioral sciences. Routledge, New York
Verrall CE, Blue GM, Loughran-Fowlds A, Kasparian N, Gecz J, Walker K et al (2019) ‘Big issues’ in neurodevelopment for children and adults with congenital heart disease. Open Heart. 6(2):e000998
Mills R, McCusker CG, Tennyson C, Hanna D (2018) Neuropsychological outcomes in CHD beyond childhood: a meta-analysis. Cardiol Young 28(3):421–431
Klouda L, Franklin WJ, Saraf A, Parekh DR, Schwartz DD (2017) Neurocognitive and executive functioning in adult survivors of congenital heart disease 12(1):91–98
Glotzbach KL, Ward JJ, Marietta J, Eckhauser AW, Winter S, Puchalski MD et al (2020) The benefits and bias in neurodevelopmental evaluation for children with congenital heart disease. Pediatr Cardiol 41(2):327–333
Lurie LA, Hagen MP, McLaughlin KA, Sheridan MA, Meltzoff AN, Rosen ML (2021) Mechanisms linking socioeconomic status and academic achievement in early childhood: cognitive stimulation and language. Cogn Dev 58:101045
Rosen ML, Hagen MP, Lurie LA, Miles ZE, Sheridan MA, Meltzoff AN et al (2020) Cognitive stimulation as a mechanism linking socioeconomic status with executive function: a longitudinal investigation. Child Dev 91(4):e762–e779
de Neubourg E, Borghans L, Coppens K, Jansen M (2018) Explaining children’s life outcomes: parental socioeconomic status, intelligence and neurocognitive factors in a dynamic life cycle model. Child Indic Res 11(5):1495–1513
Gottschling J, Hahn E, Beam CR, Spinath FM, Carroll S, Turkheimer E (2019) Socioeconomic status amplifies genetic effects in middle childhood in a large German twin sample. Intelligence 72:20–27
Tucker-Drob EM, Rhemtulla M, Harden KP, Turkheimer E, Fask DJPS (2011) Emergence of a gene × socioeconomic status interaction on infant mental ability between 10 months and 2 years. Psychol Sci. 22(1):125–33
Baier T, Lang VJSS (2019) The social stratification of environmental and genetic influences on education: new evidence using a register-based twin sample. Sociol Sci 6:143–71
Figlio DN, Freese J, Karbownik K, Roth J (2017) Socioeconomic status and genetic influences on cognitive development. Proc Natl Acad Sci U S A 114(51):13441–13446
Tucker-Drob EM, Briley DA, Harden KP (2013) Genetic and environmental influences on cognition across development and context. Curr Dir Psychol Sci. 22(5):349–55
Australian Psychological Society (2019) The future of psychology in Australia: a blueprint for better mental health outcomes for all Australians through Medicare—White Paper, Melbourne, VIC
Willems R, Ombelet F, Goossens E, De Groote K, Budts W, Moniotte S et al (2020) Long-term healthcare utilization, medical cost, and societal cost in adult congenital heart disease. Congenit Heart Dis. 15(6):399–429
Australian Government Department of Health (2019) National strategic action plan for childhood heart disease. Beyond the heart: transforming care. Australian Government Department of Health, Canberra. https://www.health.gov.au/resources/publications/national-strategic-action-plan-for-childhood-heart-disease. Updated 1 Feb 2019
Zhang M, Gale SD, Erickson LD, Brown BL, Woody P, Hedges DW (2015) Cognitive function in older adults according to current socioeconomic status. Aging Neuropsychol Cogn 22(5):534–543
Turrell G, Lynch JW, Kaplan GA, Everson SA, Helkala E-L, Kauhanen J et al (2002) Socioeconomic position across the lifecourse and cognitive function in late middle age. J Gerontol B 57(1):S43–S51
Bagge CN, Henderson VW, Laursen HB, Adelborg K, Olsen M, Madsen NL (2018) Risk of dementia in adults with congenital heart disease: population-based cohort study. Circulation 137(18):1912–1920
Downing KF, Oster ME, Olivari BS, Farr SL (2022) Early-onset dementia among privately-insured adults with and without congenital heart defects in the United States, 2015–2017. Int J Cardiol 358:34–38
Oster ME, Watkins S, Hill KD, Knight JH, Meyer RE (2017) Academic outcomes in children with congenital heart defects: a population-based cohort study. Circ Cardiovasc Qual Outcomes 10(2):e003074
Spillmann R, Polentarutti S, Ehrler M, Kretschmar O, Wehrle FM, Latal B (2023) Congenital heart disease in school-aged children: cognition, education, and participation in leisure activities. Pediatr Res. 94(4):1523–1529
Peng P, Kievit RA (2020) The development of academic achievement and cognitive abilities: a bidirectional perspective 14(1):15–20
Kovacs AH, Saidi AS, Kuhl EA, Sears SF, Silversides C, Harrison JL et al (2009) Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int J Cardiol 137(2):158–164
Jackson JL, Leslie CE, Hondorp SN (2018) Depressive and anxiety symptoms in adult congenital heart disease: prevalence, health impact and treatment. Prog Cardiovasc Dis 61(3):294–299
Westhoff-Bleck M, Briest J, Fraccarollo D, Hilfiker-Kleiner D, Winter L, Maske U et al (2016) Mental disorders in adults with congenital heart disease: unmet needs and impact on quality of life. J Affect Disord 204:180–186
McGrath LB, Kovacs AH (2019) Psychological resilience: significance for pediatric and adult congenital cardiology. Prog Pediatr Cardiol 54:101129
Bang JS, Jo S, Kim GB, Kwon BS, Bae EJ, Noh CI et al (2013) The mental health and quality of life of adult patients with congenital heart disease. Int J Cardiol 170(1):49–53
Davies A, Rogers JM, Baker K, Li L, Llerena J, das Nair R et al (2023) Combined cognitive and psychological interventions improve meaningful outcomes after acquired brain injury: a systematic review and meta-analysis. Neuropsychol Rev. https://doi.org/10.1007/s11065-023-09625-z
Meadows GN, Enticott JC, Inder B, Russell GM, Gurr R (2015) Better access to mental health care and the failure of the Medicare principle of universality 202(4):190–194
Meadows GN, Enticott JC, Inder B, Russell GM, Gurr R (2015) Better access to mental health care and the failure of the Medicare principle of universality. Med J Aust 202(4):190–194
Tran DL, Rodrigues C, du Plessis K, Zannino D, Davis GM, Celermajer DS et al (2021) Decline is not inevitable: exercise capacity trajectory in an Australian and New Zealand Fontan cohort. Heart Lung Circ 30(9):1356–1363
McDermott LM, Ebmeier KP (2009) A meta-analysis of depression severity and cognitive function. J Affect Disord 119(1):1–8
Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lönnqvist J (2008) A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord 106(1):1–27
Hammar Å, Ronold EH, Rekkedal G (2022) Cognitive impairment and neurocognitive profiles in major depression—a clinical perspective. Front Psych 13:764374
Marelli A, Miller SP, Marino BS, Jefferson AL, Newburger JW (2016) Brain in congenital heart disease across the lifespan: the cumulative burden of injury. Circulation 133(20):1951–1962
Selvanathan T, Smith JMC, Miller SP, Field TS (2022) Neurodevelopment and cognition across the lifespan in patients with single-ventricle physiology: abnormal brain maturation and accumulation of brain injuries. Can J Cardiol 38(7):977–987
Latal B, Patel P, Liamlahi R, Knirsch W, O’Gorman Tuura R, von Rhein M et al (2016) Hippocampal volume reduction is associated with intellectual functions in adolescents with congenital heart disease. Pediatr Res 80(4):531–537
Badaly D, Beers SR, Ceschin R, Lee VK, Sulaiman S, Zahner A et al (2022) Cerebellar and prefrontal structures associated with executive functioning in pediatric patients with congenital heart defects. Front Neurol. 13:827780
Pike NA, Roy B, Moye S, Cabrera-Mino C, Woo MA, Halnon NJ et al (2021) Reduced hippocampal volumes and memory deficits in adolescents with single ventricle heart disease. Brain Behav 11(2):e01977
Naef N, Schlosser L, Brugger P, Greutmann M, Oxenius A, Wehrle F et al (2021) Brain volumes in adults with congenital heart disease correlate with executive function abilities. Brain Imaging Behav 15(5):2308–2316
Rivkin MJ, Watson CG, Scoppettuolo LA, Wypij D, Vajapeyam S, Bellinger DC et al (2013) Adolescents with D-transposition of the great arteries repaired in early infancy demonstrate reduced white matter microstructure associated with clinical risk factors. J Thorac Cardiovasc Surg 146(3):543–9.e1
Rollins CK, Watson CG, Asaro LA, Wypij D, Vajapeyam S, Bellinger DC et al (2014) White matter microstructure and cognition in adolescents with congenital heart disease. J Pediatr 165(5):936–44.e442
Watson CG, Stopp C, Wypij D, Bellinger DC, Newburger JW, Rivkin MJ (2018) Altered white matter microstructure correlates with IQ and processing speed in children and adolescents post-Fontan. J Pediatr 200:140–9.e4
Ehrler M, Schlosser L, Brugger P, Greutmann M, Oxenius A, Kottke R et al (2021) Altered white matter microstructure is related to cognition in adults with congenital heart disease. Brain Commun. 3(1):fcaa224
Ehrler M, Latal B, Kretschmar O, von Rhein M, O’Gorman TR (2020) Altered frontal white matter microstructure is associated with working memory impairments in adolescents with congenital heart disease: a diffusion tensor imaging study. NeuroImage. 25:102123
Verrall CE, Chen J, Yeh C-H, Mackay MT, d’Udekem Y, Winlaw DS et al (2022) A diffusion MRI study of brain white matter microstructure in adolescents and adults with a Fontan circulation: investigating associations with resting and peak exercise oxygen saturations and cognition. NeuroImage. 36:103151
Sanz JH, Cox S, Donofrio MT, Ishibashi N, McQuillen P, Peyvandi S et al (2023) Trajectories of neurodevelopment and opportunities for intervention across the lifespan in congenital heart disease. Child Neuropsychol. 29(7):1128–1154
Donnelly JE, Hillman CH, Castelli D, Etnier JL, Lee S, Tomporowski P et al (2016) Physical activity, fitness, cognitive function, and academic achievement in children: a systematic review. Med Sci Sports Exerc 48(6):1197–1222
Chaddock-Heyman L, Hillman CH, Cohen NJ, Kramer AF III (2014) The importance of physical activity and aerobic fitness for cognitive control and memory in children. Monogr Soc Res Child Dev 79(4):25–50
Westfall DR, Gejl AK, Tarp J, Wedderkopp N, Kramer AF, Hillman CH et al (2018) Associations between aerobic fitness and cognitive control in adolescents. Front Psychol 9:1298
Kramer AF, Hahn S, Cohen NJ, Banich MT, McAuley E, Harrison CR et al (1999) Ageing, fitness and neurocognitive function. Nature 400(6743):418–419
Erickson KI, Hillman CH, Kramer AF (2015) Physical activity, brain, and cognition. Curr Opin Behav Sci 4:27–32
Lubans DR, Leahy AA, Mavilidi MF, Valkenborghs SR (2022) Physical activity, fitness, and executive functions in youth: effects, moderators, and mechanisms. In: Andersen SL (ed) Sensitive periods of brain development and preventive interventions. Springer International Publishing, Cham, pp 103–130
Cooney SJ, Campbell K, Wolfe K, DiMaria MV, Rausch CM (2021) Is neurodevelopment related to exercise capacity in single ventricle patients who have undergone Fontan palliation? Pediatr Cardiol 42(2):408–416
Miranda WR, Jain CC, Borlaug BA, Jaffe AS, Connolly HM, Burchill LJ et al (2023) Exercise capacity NT-proBNP, and Exercise Hemodynamics in Adults Post-Fontan. J Am Coll Cardiol 81(16):1590–1600
Kempny A, Dimopoulos K, Uebing A, Moceri P, Swan L, Gatzoulis MA et al (2011) Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life—single centre experience and review of published data. Eur Heart J. 33(11):1386–96
Verrall CE, Tran DL, Yang JY-M, Lubans DR, Winlaw DS, Ayer J et al (2023) Exercise as therapy for neurodevelopmental and cognitive dysfunction in people with a Fontan circulation: a narrative review. Front Pediatr 11:1111785
Tran D, Maiorana A, Ayer J, Lubans DR, Davis GM, Celermajer DS et al (2020) Recommendations for exercise in adolescents and adults with congenital heart disease. Prog Cardiovasc Dis 63(3):350–366
Tran DL, Maiorana A, Davis GM, Celermajer DS, d’Udekem Y, Cordina R (2021) Exercise testing and training in adults with congenital heart disease: a surgical perspective. Ann Thorac Surg 112(4):1045–1054
Acknowledgements
We would like to thank Ella Robinson and Michelle d’Almeida for their assistance with data collection for this study.
Funding
Open Access funding enabled and organized by CAUL and its Member Institutions. This study was supported by the NSW Health Cardiovascular Research Capacity Program—Early-Mid Career Researcher Grant (Ref: H21/174585) and the Medical Research Future Fund—Cardiovascular Health Mission—Congenital Heart Disease Grant (ARGCHDG000016).
Author information
Authors and Affiliations
Contributions
CEV curated and analyzed the data and wrote the main manuscript text. RC supervised the study. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The manuscript has not previously been published in print or electronic form and is not under consideration by any another publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Verrall, C.E., Tran, D.L., Kasparian, N.A. et al. Cognitive Functioning and Psychosocial Outcomes in Adults with Complex Congenital Heart Disease: A Cross-sectional Pilot Study. Pediatr Cardiol 45, 529–543 (2024). https://doi.org/10.1007/s00246-023-03376-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-023-03376-7